Monkeypox Information and Resources

CarePartners of Connecticut is committed to health equity and recognizes the importance of identifying at-risk communities for monkeypox and supporting vaccination efforts. It’s crucial that public health organizations, providers, and health plans work together to deliver accurate information to the community, particularly on how monkeypox is spread and by reinforcing that anyone can get monkeypox.

The CDC monkeypox website offers detailed information, including information specifically for health care professionals and on reducing stigma.

The JYNNEOS vaccine is approved for prevention of smallpox and monkeypox, and is the primary vaccine being used in the U.S. An alternative is the ACAM2000 vaccine, which is also approved to help protect against smallpox and monkeypox.

Government agencies are supplying monkeypox vaccine, and therefore, CarePartners of Connecticut does not reimburse for them (codes 90611 and 90622 are non-reimbursable). Laboratory testing for monkeypox (87593) and codes for the administration of the monkeypox vaccine are reimbursable. Consistent with American Medical Association guidance, existing CPT vaccine administration codes (90460, 90461, 90471, 90472) should be used to report the administration of vaccine products described by codes 90611 and 90622, depending on the age of the patient and the administration provided during the encounter.

To support a coordinated, equitable, and culturally relevant monkeypox response, healthcare providers are required to report cases of monkeypox to their state’s public health department. For more information on monkeypox, including information on where patients can obtain a vaccine, please refer to the Connecticut Department of Public Health.